Rossana Berardi

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 32

Top Venues

Exploration of targeted anti-tumor therapy

Cancer research communications

Journal of clinical medicine

Cancers

Università Politecnica delle Marche

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Università Politecnica delle Marche Nov 01 2015

Italy

Associate Professor

Publications

Duncan A Wheatley, Rossana Berardi, Miguel A Climent Duran, Anna Tomiak, Alastair P Greystoke, Anthony M Joshua, Hendrick-Tobias Arkenau, Lajos Géczi, Javier García Corbacho, Luis G Paz-Ares, Syed Anwer Hussain, Lubos Petruželka, Angelo Delmonte, Colombe Chappey, Joanna C Masters, Elisabete Michelon, Danielle A Murphy, Sandrine Mwewa, Rossano Cesari, Bernard Doger
First-line avelumab plus chemotherapy in patients with advanced solid tumors: results from the phase 1b/2 JAVELIN Chemotherapy Medley study. Cancer research communications (2024)
Duncan A Wheatley, Rossana Berardi, Miguel A Climent Duran, Anna Tomiak, Alastair P Greystoke, Anthony M Joshua, Hendrick-Tobias Arkenau, Lajos Géczi, Javier García Corbacho, Luis G Paz-Ares, Syed Anwer Hussain, Lubos Petruželka, Angelo Delmonte, Colombe Chappey, Joanna C Masters, Elisabete Michelon, Danielle A Murphy, Sandrine Mwewa, Rossano Cesari, Bernard Doger
First-line Avelumab plus Chemotherapy in Patients with Advanced Solid Tumors: Results from the Phase Ib/II JAVELIN Chemotherapy Medley Study. Cancer research communications 4 (6) (2024)
Duncan A Wheatley, Rossana Berardi, Miguel A Climent Duran, Anna Tomiak, Alastair P Greystoke, Anthony M Joshua, Hendrick-Tobias Arkenau, Lajos Géczi, Javier García Corbacho, Luis G Paz-Ares, Syed Anwer Hussain, Lubos Petruželka, Angelo Delmonte, Colombe Chappey, Joanna C Masters, Elisabete Michelon, Danielle A Murphy, Sandrine Mwewa, Rossano Cesari, Bernard Doger
First-line Avelumab plus Chemotherapy in Patients with Advanced Solid Tumors: Results from the Phase Ib/II JAVELIN Chemotherapy Medley Study. Cancer research communications 4 (6) (2024)
Duncan A Wheatley, Rossana Berardi, Miguel A Climent Duran, Anna Tomiak, Alastair P Greystoke, Anthony M Joshua, Hendrick-Tobias Arkenau, Lajos Géczi, Javier García Corbacho, Luis G Paz-Ares, Syed Anwer Hussain, Lubos Petruželka, Angelo Delmonte, Colombe Chappey, Joanna C Masters, Elisabete Michelon, Danielle A Murphy, Sandrine Mwewa, Rossano Cesari, Bernard Doger
First-line Avelumab plus Chemotherapy in Patients with Advanced Solid Tumors: Results from the Phase Ib/II JAVELIN Chemotherapy Medley Study. Cancer research communications 4 (6) (2024)
Zelmira Ballatore, Amalia Goudas, Francesco Bozzi, Alessandra Lucarelli, Michela Burattini, Giulia Ricci, Francesco Savino, Rossana Berardi
A single experience in the conduction of clinical trial during COronaVIrusDisease-2019 pandemic. Exploration of targeted anti-tumor therapy 4 (5) (2023)
Lorenzo Ruggieri, Anna Moretti, Rossana Berardi, Maria Silvia Cona, Davide Dalu, Cecilia Villa, Davide Chizzoniti, Sheila Piva, Anna Gambaro, Nicla La Verde
Host-Related Factors in the Interplay among Inflammation, Immunity and Dormancy in Breast Cancer Recurrence and Prognosis: An Overview for Clinicians. International journal of molecular sciences 24 (5) (2023)
Zelmira Ballatore, Francesco Bozzi, Sara Cardea, Francesco Domenico Savino, Antonella Migliore, Valentina Tarantino, Natalia Chiodi, Elisa Ambrosini, Francesca Bianchi, Gaia Goteri, Alessandra Filosa, Francesca Barbisan, Elisa Bartoli, Roberto Papa, Rossana Berardi
Molecular Tumour Board (MTB): From Standard Therapy to Precision Medicine. Journal of clinical medicine 12 (20) (2023)
Marco Tagliamento, Alessandra Gennari, Matteo Lambertini, Ramón Salazar, Nadia Harbeck, Lucia Del Mastro, Juan Aguilar, Mark Bower, Rachel Sharkey, Alessia Dalla Pria, Andrea Plaja, Amanda Jackson, Jasmine Handford, Ailsa Sita-Lumsden, Clara Martinez-Vila, Marta Matas, Ana Miguel Rodriguez, Bruno Vincenzi, Giuseppe Tonini, Alexia Bertuzzi, Joan Brunet, Paolo Pedrazzoli, Francesca D'Avanzo, Federica Biello, Alasdair Sinclair, Alvin J X Lee, Sabrina Rossi, Gianpiero Rizzo, Oriol Mirallas, Isabel Pimentel, Maria Iglesias, Ana Sanchez de Torre, Annalisa Guida, Rossana Berardi, Alberto Zambelli, Carlo Tondini, Marco Filetti, Francesca Mazzoni, Uma Mukherjee, Nikolaos Diamantis, Maria Concetta Fargnoli, Avinash Aujayeb, Aleix Prat, Michela Libertini, Salvatore Grisanti, Maura Rossi, Federica Zoratto, Daniele Generali, Cristina Saura, Gary H Lyman, Nicole M Kuderer, David James Pinato, Alessio Cortellini, null null
Pandemic Phase-Adjusted Analysis of COVID-19 Outcomes Reveals Reduced Intrinsic Vulnerability and Substantial Vaccine Protection From Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Federica Pecci, Luca Cantini, Valeria Cognigni, Fabiana Perrone, Giulia Mazzaschi, Veronica Agostinelli, Giulia Mentrasti, Elda Favari, Michele Maffezzoli, Alessio Cortellini, Francesca Rossi, Rebecca Chiariotti, Francesco Maria Venanzi, Giuseppe Lo Russo, Giulia Galli, Claudia Proto, Monica Ganzinelli, Francesca Tronconi, Francesca Morgese, Carla Campolucci, Marco Moretti, Arianna Vignini, Marcello Tiseo, Roberta Minari, Marco Luigi Bruno Rocchi, Sebastiano Buti, Rossana Berardi
Prognostic Impact of Blood Lipid Profile in Patients With Advanced Solid Tumors Treated With Immune Checkpoint Inhibitors: A Multicenter Cohort Study. The oncologist (2023)
Veronica Agostinelli, Zelmira Ballatore, Giulia Ricci, Alessandra Lucarelli, Michela Burattini, Lorenzo Mariotti, Claudia Catani, Valentina Tarantino, Rossana Berardi
Impact of coronavirus disease 2019 pandemic on good clinical practice trials in oncology. Exploration of targeted anti-tumor therapy 4 (5) (2023)
Lorenzo Ruggieri, Anna Moretti, Rossana Berardi, Maria Silvia Cona, Davide Dalu, Cecilia Villa, Davide Chizzoniti, Sheila Piva, Anna Gambaro, Nicla La Verde
Host-Related Factors in the Interplay among Inflammation, Immunity and Dormancy in Breast Cancer Recurrence and Prognosis: An Overview for Clinicians. International journal of molecular sciences 24 (5) (2023)
Marco Tagliamento, Alessandra Gennari, Matteo Lambertini, Ramón Salazar, Nadia Harbeck, Lucia Del Mastro, Juan Aguilar, Mark Bower, Rachel Sharkey, Alessia Dalla Pria, Andrea Plaja, Amanda Jackson, Jasmine Handford, Ailsa Sita-Lumsden, Clara Martinez-Vila, Marta Matas, Ana Miguel Rodriguez, Bruno Vincenzi, Giuseppe Tonini, Alexia Bertuzzi, Joan Brunet, Paolo Pedrazzoli, Francesca D'Avanzo, Federica Biello, Alasdair Sinclair, Alvin J X Lee, Sabrina Rossi, Gianpiero Rizzo, Oriol Mirallas, Isabel Pimentel, Maria Iglesias, Ana Sanchez de Torre, Annalisa Guida, Rossana Berardi, Alberto Zambelli, Carlo Tondini, Marco Filetti, Francesca Mazzoni, Uma Mukherjee, Nikolaos Diamantis, Maria Concetta Fargnoli, Avinash Aujayeb, Aleix Prat, Michela Libertini, Salvatore Grisanti, Maura Rossi, Federica Zoratto, Daniele Generali, Cristina Saura, Gary H Lyman, Nicole M Kuderer, David James Pinato, Alessio Cortellini, null null
Pandemic Phase-Adjusted Analysis of COVID-19 Outcomes Reveals Reduced Intrinsic Vulnerability and Substantial Vaccine Protection From Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Lorenzo Ruggieri, Anna Moretti, Rossana Berardi, Maria Silvia Cona, Davide Dalu, Cecilia Villa, Davide Chizzoniti, Sheila Piva, Anna Gambaro, Nicla La Verde
Host-Related Factors in the Interplay among Inflammation, Immunity and Dormancy in Breast Cancer Recurrence and Prognosis: An Overview for Clinicians. International journal of molecular sciences 24 (5) (2023)
Valeria Cognigni, Federica Pecci, Alessio Lupi, Giada Pinterpe, Chiara De Filippis, Cristiano Felicetti, Luca Cantini, Rossana Berardi
The Landscape of ALK-Rearranged Non-Small Cell Lung Cancer: A Comprehensive Review of Clinicopathologic, Genomic Characteristics, and Therapeutic Perspectives. Cancers 14 (19) (2022)
Giulia Mentrasti, Luca Cantini, Clizia Zichi, Nicola D'Ostilio, Fabio Gelsomino, Erika Martinelli, Rita Chiari, Nicla La Verde, Renato Bisonni, Valeria Cognigni, Giada Pinterpe, Federica Pecci, Antonella Migliore, Giacomo Aimar, Francesca De Vita, Donatella Traisci, Andrea Spallanzani, Giulia Martini, Linda Nicolardi, Maria Silvia Cona, Maria Giuditta Baleani, Marco Luigi Bruno Rocchi, Rossana Berardi
Alarming Drop in Early Stage Colorectal Cancer Diagnoses After COVID-19 Outbreak: A Real-World Analysis from the Italian COVID-DELAY Study. The oncologist 27 (9) (2022)
Mariangela Torniai, Veronica Agostinelli, Luca Cantini, Carolina Liguori, Francesca Morgese, Silvia Rinaldi, Laura Scortichini, Rossana Berardi
Management of lung cancer patients during COVID-19 pandemic: dos, don'ts and don't knows. Exploration of targeted anti-tumor therapy 3 (3) (2022)
Luca Cantini, Federica Pecci, Filippo Merloni, Andrea Lanese, Edoardo Lenci, Francesco Paoloni, Joachim G J V Aerts, Rossana Berardi
Old but gold: the role of drug combinations in improving response to immune check-point inhibitors in thoracic malignancies beyond NSCLC. Exploration of targeted anti-tumor therapy 2 (1) (2021)
Mirco Pistelli, Valentina Natalucci, Laura Scortichini, Veronica Agostinelli, Edoardo Lenci, Sonia Crocetti, Filippo Merloni, Lucia Bastianelli, Marina Taus, Daniele Fumelli, Gloria Giulietti, Claudia Cola, Marianna Capecci, Roberta Serrani, Maria Gabriella Ceravolo, Maurizio Ricci, Albano Nicolai, Elena Barbieri, Giulia Nicolai, Zelmira Ballatore, Agnese Savini, Rossana Berardi
The Impact of Lifestyle Interventions in High-Risk Early Breast Cancer Patients: A Modeling Approach from a Single Institution Experience. Cancers 13 (21) (2021)
Elena Maccaroni, Edoardo Lenci, Veronica Agostinelli, Valeria Cognigni, Riccardo Giampieri, Paola Mazzanti, Marzia Di Pietro Paolo, Francesca Bianchi, Cristiana Brugiati, Laura Belvederesi, Silvia Pagliaretta, Alessandra Mandolesi, Marina Scarpelli, Alberto Murrone, Francesca Morgese, Zelmira Ballatore, Rossana Berardi
Lynch syndrome-associated lung cancer: pitfalls of an immunotherapy-based treatment strategy in an unusual tumor type. Exploration of targeted anti-tumor therapy 2 (3) (2021)
Edoardo Lenci, Luca Cantini, Federica Pecci, Valeria Cognigni, Veronica Agostinelli, Giulia Mentrasti, Alessio Lupi, Nicoletta Ranallo, Francesco Paoloni, Silvia Rinaldi, Linda Nicolardi, Andrea Caglio, Sophie Aerts, Alessio Cortellini, Corrado Ficorella, Rita Chiari, Massimo Di Maio, Anne-Marie C Dingemans, Joachim G J V Aerts, Rossana Berardi
The Gustave Roussy Immune (GRIm)-Score Variation Is an Early-on-Treatment Biomarker of Outcome in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Pembrolizumab. Journal of clinical medicine 10 (5) (2021)
Luca Cantini, Lucia Bastianelli, Alessio Lupi, Giada Pinterpe, Federica Pecci, Giovanni Belletti, Rosa Stoico, Francesca Vitarelli, Marco Moretti, Nicoletta Onori, Riccardo Giampieri, Marco Bruno Luigi Rocchi, Rossana Berardi
Seroprevalence of SARS-CoV-2-Specific Antibodies in Cancer Patients Undergoing Active Systemic Treatment: A Single-Center Experience from the Marche Region, Italy. Journal of clinical medicine 10 (7) (2021)
Edoardo Lenci, Giulia Marcantognini, Valeria Cognigni, Alessio Lupi, Silvia Rinaldi, Luca Cantini, Ilaria Fiordoliva, Anna Lisa Carloni, Marco Rocchi, Lina Zuccatosta, Stefano Gasparini, Rossana Berardi
Tumor burden as possible biomarker of outcome in advanced NSCLC patients treated with immunotherapy: a single center, retrospective, real-world analysis. Exploration of targeted anti-tumor therapy 2 (3) (2021)
Valeria Cognigni, Nicoletta Ranallo, Francesca Tronconi, Francesca Morgese, Rossana Berardi
Potential benefit of β-glucans as adjuvant therapy in immuno-oncology: a review. Exploration of targeted anti-tumor therapy 2 (2) (2021)
Rossana Berardi, Roberto Papa, Valerio Mattia Scandali, Mariangela Torniai, Maurizio Blasi, Andrea Brusa, Franco Elisei, Gian Luca Gregori, Giancarlo Laurenzi, Luca Marinelli, Massimiliano Marinelli, Graziella Mazzoli, Fabrizio Volpini, Michele Caporossi
Contrasting Fake News in Oncology: The First Declaration of Good Communication. JCO global oncology 7 (2021)
Alessandra Raimondi, Federica Palermo, Michele Prisciandaro, Massimo Aglietta, Lorenzo Antonuzzo, Giuseppe Aprile, Rossana Berardi, Giovanni G Cardellino, Giovanni De Manzoni, Ferdinando De Vita, Massimo Di Maio, Lorenzo Fornaro, Giovanni L Frassineti, Cristina Granetto, Francesco Iachetta, Sara Lonardi, Roberto Murialdo, Elena Ongaro, Francesca Pucci, Margherita Ratti, Nicola Silvestris, Valeria Smiroldo, Andrea Spallanzani, Antonia Strippoli, Stefano Tamberi, Emiliano Tamburini, Alberto Zaniboni, Maria Di Bartolomeo, Chiara Cremolini, Carlo Sposito, Vincenzo Mazzaferro, Filippo Pietrantonio
TremelImumab and Durvalumab Combination for the Non-OperatIve Management (NOM) of Microsatellite InstabiliTY (MSI)-High Resectable Gastric or Gastroesophageal Junction Cancer: The Multicentre, Single-Arm, Multi-Cohort, Phase II INFINITY Study. Cancers 13 (11) (2021)
Federica Pecci, Luca Cantini, Alessandro Bittoni, Edoardo Lenci, Alessio Lupi, Sonia Crocetti, Enrica Giglio, Riccardo Giampieri, Rossana Berardi
Beyond Microsatellite Instability: Evolving Strategies Integrating Immunotherapy for Microsatellite Stable Colorectal Cancer. Current treatment options in oncology 22 (8) (2021)
Giulia Mentrasti, Laura Scortichini, Mariangela Torniai, Riccardo Giampieri, Francesca Morgese, Silvia Rinaldi, Rossana Berardi
Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH): Optimal Management. Therapeutics and clinical risk management 16 (2020)
Rossana Berardi, Silvia Rinaldi, Giulio Belfiori, Stefano Partelli, Stefano Crippa, Mariangela Torniai, Massimo Falconi
The Role of Hyponatraemia Before Surgery in Patients With Radical Resected Pancreatic Cancer. Clinical Medicine Insights. Oncology 14 (2020)
Rossana Berardi, Francesca Morgese, Silvia Rinaldi, Mariangela Torniai, Giulia Mentrasti, Laura Scortichini, Riccardo Giampieri
Benefits and Limitations of a Multidisciplinary Approach in Cancer Patient Management. Cancer management and research 12 (2020)
Mariangela Torniai, Laura Scortichini, Francesca Tronconi, Corrado Rubini, Francesca Morgese, Silvia Rinaldi, Paola Mazzanti, Rossana Berardi
Systemic treatment for lung carcinoids: from bench to bedside. Clinical and translational medicine 8 (1) (2019)
Rossana Berardi, Mariangela Torniai, Stefano Partelli, Corrado Rubini, Silvia Pagliaretta, Agnese Savini, Vanessa Polenta, Matteo Santoni, Riccardo Giampieri, Sofia Onorati, Federica Barucca, Alberto Murrone, Francesca Bianchi, Massimo Falconi
Impact of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) single nucleotide polymorphisms on outcome in gastroenteropancreatic neuroendocrine neoplasms. PloS one 13 (5) (2018)
Rossana Berardi, Mariangela Torniai, Sara Pusceddu, Francesca Spada, Toni Ibrahim, Maria Pia Brizzi, Lorenzo Antonuzzo, Piero Ferolla, Francesco Panzuto, Nicola Silvestris, Stefano Partelli, Benedetta Ferretti, Federica Freddari, Calogero Gucciardino, Enrica Testa, Laura Concas, Sabina Murgioni, Alberto Bongiovanni, Clizia Zichi, Nada Riva, Maria Rinzivillo, Oronzo Brunetti, Lucio Giustini, Francesco Di Costanzo, Gianfranco Delle Fave, Nicola Fazio, Filippo De Braud, Massimo Falconi, Stefano Cascinu
Prognostic impact of the cumulative dose and dose intensity of everolimus in patients with pancreatic neuroendocrine tumors. Cancer medicine 6 (7) (2017)

Rossana Berardi.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Rossana Berardi